Brainstorm Cell Therapeutics reported $2.24M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Alterity Therapeutics Limited AUD 8.67M 893.38K Dec/2025
Biogen USD 1.96B 69.6M Mar/2026
Brainstorm Cell Therapeutics USD 2.24M 197K Dec/2025
Cipla INR 59.27B 1.71B Mar/2026
Clal Biotechnology ILS 5.15M 9.47M Dec/2022
Compugen USD 11.29M 1.51M Dec/2025
CSL USD 5.7B 2.82B Dec/2025
Cytokinetics USD 200.58M 4.46M Mar/2026
Gilead Sciences USD 23.52B 18.55B Mar/2026
Grifols EUR 1.99B 217.4M Dec/2025
Halozyme Therapeutics USD 192.19M 18.88M Mar/2026
Mesoblast USD 82.31M 26.16M Dec/2025